As of 10:40:10 am GMT-4. Market open.

Soleno Therapeutics, Inc. (SLNO) Follow Add holdings 76.26-0.63 (-0.82%) At close: May 27 at 4:00:00 PM EDT Major Holders Insider Roster Insider Transactions Insider Sentiment Major Holders ...

Soleno Therapeutics, Inc. (SLNO) earnings report: revenue, EPS, surprise, history, news and analysis. Skip to content Home page Seeking Alpha - Power to Investors ...

The European Medicines Agency (EMA) has validated the marketing authorisation application (MAA) submitted by Soleno ...

Awareness Month, which seeks to raise recognition and push for research of this rare genomic imprinting disorder. PWS is estimated to affect about one in 20 000 individuals1 yet, until now, people ...

Spero Therapeutics, Inc. (NASDAQ:SPRO) saw its stock soar by 240% after announcing highly encouraging results from its Phase ...

TQ Therapeutics GmbH (TQx) has acquired Juno Therapeutics GmbH, a cell therapy company, through a share purchase agreement.

A development deal with Biogen Inc. could eventually bring City Therapeutics Inc. about $1 billion in milestone payments. Privately held City Therapeutics is getting $46 million in the deal. That ...

Spero Therapeutics and partner GSK are stopping a late-stage trial of an experimental oral drug for complicated urinary tract ...

Eli Lilly is expanding its efforts to advance next-generation pain medications. | Eli Lilly is expanding its efforts to ...

Alaunos Therapeutics ( ($TCRT) ) just unveiled an announcement. On May 19, 2025, Alaunos Therapeutics entered into an equity purchase agreement ...